[1]
Ejlertsen, B. et al. 2008. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: Indirect comparison of dose and schedule in DBCG trials 77, 82, and 89. Acta Oncologica. 47, 4 (Jan. 2008), 662–671. DOI:https://doi.org/10.1080/02841860801989761.